Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokine-binding proteins: stimulating antagonists

B Klein1, H Brailly

  • 1Institute for Molecular Genetics, CNRS, Montpellier, France.

Immunology Today
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Numerical simulation of vertical cavity surface emitting lasers.

Optics express·2009
Same author

[Colonic perforation after extracorporeal shock wave lithotripsy].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

Thyroid surgery in Burkina Faso, West Africa: experience from a surgical help program.

World journal of surgery·2008
Same author

[Oocyte and embryo quality: do the apoptotic markers have a place in the preimplantation genetic diagnostic?].

Gynecologie, obstetrique & fertilite·2008
Same author

[Could apoptotic markers help the exploration of male infertility?].

Gynecologie, obstetrique & fertilite·2008
Same author

ETV6 mutations and loss in AML-M0.

Leukemia·2008
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

Cytokine-binding proteins (CBPs) can treat diseases but form stable complexes. Researchers propose CBPs may act as agonists or antagonists based on pharmacokinetics, with a potential clearance mechanism for these complexes.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Cytokine-binding proteins (CBPs) inhibit cytokine-receptor interactions.
  • CBPs offer potential therapeutic strategies for cytokine-mediated diseases.
  • A key challenge is the in vivo stabilization of cytokines into CBP-cytokine complexes.

Purpose of the Study:

  • To explore the dual agonist/antagonist potential of CBPs.
  • To investigate the influence of pharmacokinetic properties on CBP function.
  • To propose a mechanism for clearing stable CBP-cytokine complexes.

Main Methods:

  • Theoretical discussion of CBP behavior based on pharmacokinetic characteristics.
  • Analysis of CBP-cytokine complex stability and clearance pathways.

Related Experiment Videos

Main Results:

  • CBPs may function as either agonists or antagonists depending on their in vivo pharmacokinetics.
  • Stable cytokine-CBP complexes present a pharmacokinetic challenge.
  • A potential clearance mechanism for these complexes is suggested.

Conclusions:

  • The pharmacological activity of CBPs can be modulated by their pharmacokinetic profile.
  • Understanding CBP pharmacokinetics is crucial for therapeutic development.
  • Further research into complex clearance mechanisms is warranted for effective CBP-based therapies.